BENJAMIN DAVIS: Open Payments
NPI 1609247477 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,411 in 107 payments from 27 companies in 2025. Trend: 2023 $2,171 · 2024 $2,072 · 2025 $2,411
Food & beverage: $2,325Education: $87
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $272 |
| GlaxoSmithKline, LLC. | 15 | $229 |
| Regeneron Healthcare Solutions, Inc. | 6 | $185 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $177 |
| Lilly USA, LLC | 9 | $171 |
| Phathom Pharmaceuticals, Inc. | 2 | $158 |
| Viatris Specialty LLC | 7 | $152 |
| ABBVIE INC. | 6 | $135 |
| Verona Pharma, Inc. | 5 | $131 |
| Amgen Inc. | 6 | $108 |
Products named: WINREVAIR, DUPIXENT, VOQUEZNA, YUPELRI, JARDIANCE, Ohtuvayre, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
